Alexander Kristian

557 total citations
19 papers, 448 citations indexed

About

Alexander Kristian is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Alexander Kristian has authored 19 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Alexander Kristian's work include Radiopharmaceutical Chemistry and Applications (12 papers), DNA Repair Mechanisms (3 papers) and Neuroendocrine Tumor Research Advances (3 papers). Alexander Kristian is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (12 papers), DNA Repair Mechanisms (3 papers) and Neuroendocrine Tumor Research Advances (3 papers). Alexander Kristian collaborates with scholars based in Germany, Norway and United States. Alexander Kristian's co-authors include Urs B. Hagemann, Jenny Karlsson, Roger M. Bjerke, Alan Cuthbertson, Christine Ellingsen, Dominik Mumberg, Olav B. Ryan, Véronique Cruciani, Hartwig Hennekes and Marit Renée Myhre and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Alexander Kristian

19 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alexander Kristian Germany	10	250	216	183	83	55	19	448
Dijie Liu United States	15	263 1.1×	126 0.6×	103 0.6×	187 2.3×	31 0.6×	27	499
Sophie Poty France	15	475 1.9×	215 1.0×	172 0.9×	117 1.4×	65 1.2×	25	720
Martin Bakht Iran	15	216 0.9×	118 0.5×	336 1.8×	136 1.6×	50 0.9×	26	588
Reece Goiffon United States	10	140 0.6×	137 0.6×	107 0.6×	195 2.3×	117 2.1×	32	507
Charlot Vandevoorde South Africa	19	358 1.4×	101 0.5×	283 1.5×	226 2.7×	77 1.4×	43	717
Cindy R. Fischer Switzerland	11	287 1.1×	125 0.6×	99 0.5×	96 1.2×	31 0.6×	14	491
Junie Chea United States	12	161 0.6×	142 0.7×	43 0.2×	105 1.3×	91 1.7×	18	348
Deni Hardiansyah Indonesia	13	301 1.2×	89 0.4×	71 0.4×	65 0.8×	18 0.3×	39	395
Rosemery Membreno United States	11	443 1.8×	120 0.6×	71 0.4×	198 2.4×	37 0.7×	13	568
D.P. Bergsma United States	10	178 0.7×	97 0.4×	131 0.7×	211 2.5×	40 0.7×	23	459

Countries citing papers authored by Alexander Kristian

Since Specialization

Citations

This map shows the geographic impact of Alexander Kristian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Kristian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Kristian more than expected).

Fields of papers citing papers by Alexander Kristian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Kristian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Kristian. The network helps show where Alexander Kristian may publish in the future.

Co-authorship network of co-authors of Alexander Kristian

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Kristian. A scholar is included among the top collaborators of Alexander Kristian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Kristian. Alexander Kristian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Pettersen, Solveig, Abhilash Pandya, Mads H. Haugen, et al.. (2024). The SRC-family serves as a therapeutic target in triple negative breast cancer with acquired resistance to chemotherapy. British Journal of Cancer. 131(10). 1656–1667. 7 indexed citations

Karlsson, Jenny, Urs B. Hagemann, Véronique Cruciani, et al.. (2023). Efficacy of a HER2-Targeted Thorium-227 Conjugate in a HER2-Positive Breast Cancer Bone Metastasis Model. Cancers. 15(13). 3419–3419. 4 indexed citations

Böhnke, Niels, Bård Indrevoll, Stefanie Hammer, et al.. (2023). Mono- and multimeric PSMA-targeting small molecule-thorium-227 conjugates for optimized efficacy and biodistribution in preclinical models. European Journal of Nuclear Medicine and Molecular Imaging. 51(3). 669–680. 9 indexed citations

Zitzmann-Kolbe, Sabine, Alexander Kristian, Dieter Zopf, et al.. (2023). A Targeted Thorium-227 Conjugate Demonstrates Efficacy in Preclinical Models of Acquired Drug Resistance and Combination Potential with Chemotherapeutics and Antiangiogenic Therapies. Molecular Cancer Therapeutics. 22(9). 1073–1086. 3 indexed citations

Suurs, Frans V., Ingrid Moen, Danique Giesen, et al.. (2022). ⁸⁹Zr-3,2-HOPO-mesothelin antibody PET imaging reflects tumor uptake of mesothelin targeted ²²⁷Th-conjugate therapy in mice. Journal of Nuclear Medicine. 63(11). jnumed.121.263079–jnumed.121.263079. 6 indexed citations

Mobergslien, Anne, Ingrid Moen, Alexander Kristian, et al.. (2022). Tumor growth inhibition and immune system activation following treatment with thorium-227 conjugates and PD-1 check-point inhibition in the MC-38 murine model. Frontiers in Medicine. 9. 1033303–1033303. 6 indexed citations

Hammer, Stefanie, Urs B. Hagemann, Sabine Zitzmann-Kolbe, et al.. (2019). Preclinical Efficacy of a PSMA-Targeted Thorium-227 Conjugate (PSMA-TTC), a Targeted Alpha Therapy for Prostate Cancer. Clinical Cancer Research. 26(8). 1985–1996. 94 indexed citations

Hagemann, Urs B., Christine Ellingsen, Joachim Schuhmacher, et al.. (2019). Mesothelin-Targeted Thorium-227 Conjugate (MSLN-TTC): Preclinical Evaluation of a New Targeted Alpha Therapy for Mesothelin-Positive Cancers. Clinical Cancer Research. 25(15). 4723–4734. 86 indexed citations

Karlsson, Jenny, Christine Ellingsen, Véronique Cruciani, et al.. (2019). Synergistic Effect of a HER2 Targeted Thorium-227 Conjugate in Combination with Olaparib in a BRCA2 Deficient Xenograft Model. Pharmaceuticals. 12(4). 155–155. 29 indexed citations

10.

Kristian, Alexander, et al.. (2019). Influx rate of 18F-fluoroaminosuberic acid reflects cystine/glutamate antiporter expression in tumour xenografts. European Journal of Nuclear Medicine and Molecular Imaging. 46(10). 2190–2198. 15 indexed citations

11.

Hagemann, Urs B., Véronique Cruciani, Antje M. Wengner, et al.. (2019). Synergistic Effect of a Mesothelin-Targeted ²²⁷Th Conjugate in Combination with DNA Damage Response Inhibitors in Ovarian Cancer Xenograft Models. Journal of Nuclear Medicine. 60(9). 1293–1300. 40 indexed citations

12.

Hagemann, Urs B., Alexander Kristian, Christine Ellingsen, et al.. (2019). Preclinical Combination Studies of an FGFR2 Targeted Thorium-227 Conjugate and the ATR Inhibitor BAY 1895344. International Journal of Radiation Oncology*Biology*Physics. 105(2). 410–422. 18 indexed citations

13.

Hagemann, Urs B., Sabine Zitzmann-Kolbe, Alexander Kristian, et al.. (2019). Abstract 3937: MSLN-TTC (BAY 2287411) demonstrates increased activity in comparison to standard of care chemotherapy in models of acquired drug resistance. 3937–3937. 1 indexed citations

14.

Cuthbertson, Alan, et al.. (2019). In-vivo Comparison of Thorium-227 and Zirconium-89 Labeled 3,2-HOPO Mesothelin Antibody-chelator Conjugate. Journal of medical imaging and radiation sciences. 50(1). S26–S26. 3 indexed citations

15.

Hagemann, Urs B., Anette Sommer, Alexander Kristian, et al.. (2017). Abstract 5199: Preclinical activity of the FGFR2-targeted thorium-227 conjugate in preclinical models of colorectal, gastric and triple-negative breast cancer. Cancer Research. 77(13_Supplement). 5199–5199. 4 indexed citations

16.

Karlsson, Jenny, Urs B. Hagemann, Christoph A. Schatz, et al.. (2017). Abstract 5857: HER2-targeted thorium-227 conjugate (HER2-TTC): Efficacy in a HER2 positive orthotopic bone model. Cancer Research. 77(13_Supplement). 5857–5857. 6 indexed citations

17.

Karlsson, Jenny, Urs B. Hagemann, Christoph A. Schatz, et al.. (2017). Abstract 5859: HER2-targeted thorium-227 conjugate (HER2-TTC): Efficacy in preclinical models of trastuzumab and T-DM1 resistance. Cancer Research. 77(13_Supplement). 5859–5859. 10 indexed citations

18.

Hammer, Stefanie, Christine Ellingsen, Derek Grant, et al.. (2017). Abstract 5200: Preclinical pharmacology of the PSMA-targeted thorium-227 conjugate PSMA-TTC: a novel targeted alpha therapeutic for the treatment of prostate cancer. Cancer Research. 77(13_Supplement). 5200–5200. 13 indexed citations

19.

Almåsbak, Hilde, Even Walseng, Alexander Kristian, et al.. (2015). Inclusion of an IgG1-Fc spacer abrogates efficacy of CD19 CAR T cells in a xenograft mouse model. Gene Therapy. 22(5). 391–403. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact